{
    "nctId": "NCT02447211",
    "briefTitle": "Topical Doxepin for Radiation-induced Dermatitis",
    "officialTitle": "Topical Doxepin for Prevention and Management of Radiation-induced Dermatitis",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Grading of dermatitis was performed according to the Radiation Therapy Oncology Group acute radiation morbidity scoring criteria",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female with a diagnosis of, breast adenocarcinoma and be referred for post-operative radiotherapy with or without concurrent chemotherapy and with or without mastectomy\n* Participants must not be pregnant.\n* Participants treated with a total dose of 5000 cGy (25 fractions of 200 cGy, 5 days per week\n\nExclusion Criteria:\n\n* Patients who are not eligible\n* The presence of skin diseases in the radiation area\n* Patients have constipation, xerostomia, blurred vision, urinary retention\n* Hypersensitivity to doxepin",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}